lilly-logo-2--1
Photo: Courtesy of Eli Lilly
4 April 2017Big Pharma

UK Supreme Court hears Eli Lilly dispute with Actavis

A five-year dispute between Eli Lilly and Actavis over a cancer drug is being heard today at the UK Supreme Court.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
12 July 2017   The UK Supreme Court has reformulated the three questions that should be asked when testing for equivalent patent infringement.
Big Pharma
7 July 2017   The UK Supreme Court has ruled that Actavis’s generic versions of cancer drug Alimta directly infringe patents owned by Eli Lilly, reversing two earlier decisions.